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Abstract
Background: Primary orthostatic tremor is a rare disorder that is still under-diagnosed or misdiagnosed. Motor
symptoms are fairly characteristics but the real impact on the patient’s every day life and quality of life is
under-estimated. The ”how my patients taught me” format describes the impact on the patients’ every day life with
their own words, which is rarely done.
Case presentation: A 46 year old lady was diagnosed primary orthostatic tremor (POT) based on the cardinal
symptoms: feelings of instability, leg tremor and fear of falling in the standing position, improvement with walking and
disappearance while sitting, frequency of Tremor in the 13–18Hz range, normal neurological examination. She gives
illustrative examples of her disability in every day life activity (shower, public transportation, shopping). She reports how
she felt stigmatized by her “invisible disorder”. As a consequence, she developed anxiety depression and social phobia.
All these troubles are unknown or under recognized by doctors and family.
Conclusions: We review the clinical signs of POT that may help to increase the awareness of doctors and improve
the diagnosis accuracy, based on the motor symptoms and description of the every day life disability, as reported by
the patient. Non-motor symptoms (including somatic concerns, anxiety, depression, and social phobia) should be
better considered in POT as they have a major impact on quality of life. Pharmacological treatments (clonazepam,
gabapentin) may be helpful but have a limited effect over the years as the patients experience a worsening of their
condition. On the long term follow-up, there are still unmet needs in POT, and new therapeutic avenues may be based
on the pathophysiology by modulating the cerebello-thalamo-cortical network.
Background
Feelings of instability and fear of falling are frequent
complaints in elderly subjects and have a strong impact
on quality of life. Although these features are fairly
typical of primary orthostatic tremor (POT) [1], this rare
condition is likely under-diagnosed (mean delay of
diagnosis = 4.5–9.6 years, range = 0–44) [2–4].
Nevertheless, this condition is relatively easy to diagnose
when you listen carefully to your patients, as they often
report the main clinical features: lower body tremor acti-
vated upon standing (with feelings of unsteadiness and
decreased time immobile in the upright position) which is
improved by walking and absent when sitting or lying
down. The unique electrophysiological signature charac-
teristic of primary orthostatic tremor is a 13–18 Hz
tremor in the lower limb muscles (and sometimes the
trunk) in the standing position [1–4].
Case presentation
A 46-year-old lady was diagnosed with “primary ortho-
static tremor” after 10 years of undiagnosed symptoms:
she complained of fatigue, stiffness of the legs, fear of
falling and feelings of instability. Her first symptoms
occurred when she had to stand still for an unusually
long time (she was a singer in an amateur choir). Over
time, three general practitioners examined her, and the
proposed diagnoses were depression, chronic fatigue
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syndrome, and functional disorders, for which she was
prescribed antidepressant therapy without any beneficial
effect. Eventually, based on the description of her clinical
symptoms, a neurologist suspected the diagnosis of POT
when she mentioned that the symptoms occurred in the
standing position. Neurological examination was normal,
however, in a prolonged standing position, the neu-
rologist observed fast trembling of the hem of her skirt,
revealing her leg and thigh orthostatic tremor. Electro-
physiological assessment confirmed the diagnosis of
POT (frequency: 17Hz) Gabapentin (up to 300 mg/day)
was not well tolerated. Clonazepam (3 mg/day) was
prescribed with a partial benefit (initial subjective im-
provement of 50% in daily life) and was increased up to
4 mg/day according to the patient’s needs.
Although the patient further increased the dose of clo-
nazepam up to 4.5 mg/day (higher doses were not toler-
ated due to drowsiness), she reported that the duration
of standing position without support decreased progres-
sively over the following 5 years, with an important im-
pact on her every day life. Here is the description of
everyday life with POT by the patient: “Each morning
presented numerous obstacles: I have to sit to take a
shower and wash my hair; I could not use the hairdryer
standing in front of the mirror and I hastily brush my
teeth and put on her makeup; I have to put on my trou-
sers while seated. Cooking breakfast was not without its
challenges either: I constantly have to lean on the sur-
roundings while washing the dishes, and I am afraid to
use a stool to put away her dishes in a high cupboard.
Then, I race to the metro. One particular morning, I felt
very uncomfortable standing in a compact crowd and
asked a fellow passenger for a seat. The passenger
looked very annoyed and muttered “you are not dis-
abled!”, and I felt ashamed. My work environment is also
full of uncomfortable moments in which standing is
hard to avoid, such as taking the elevator, making copies
at the copy machine, and long lines in the cafeteria. I
would deliberately avoid friends to skip long conversa-
tions in the standing position, which elicited quizzical
looks: “maybe she isn’t in a good mood?”, they would
think. When I went back to my desk, I felt exhausted
although it was only mid-day. In the evening, shopping
at the grocery was a nightmare, especially standing in
line at the cashier. I would skip chorale rehearsal, as it
was too tiring to remain standing. Moreover, my family
did not understand why I was so sad, depressed, anxious,
and “phobic” about many activities, such as going out,
visiting exhibitions, etc. I feel stigmatized by an invisible
disease, and I have progressively lost my self-esteem; I
had the impression of being misunderstood and that
people were not taking my troubles seriously. The diag-
nosis was a relief. At last, I could explain my troubles in
simple words. Eventually, I have joined the patient’s
association in order to increase the awareness of people
and doctors.
Discussion and conclusions
What I have learned from this patient and many others
is that the impact on daily life is under-estimated, as
doctors often do not realize how many activities may be-
come restricted or impossible with POT. As illustrated
by this observation, the detailed description of limita-
tions in everyday life activities, with special attention to
those while standing, corresponds to the (mainly motor)
key diagnosis features [1–4] of POT (Table 1) and may
help non-neurologists to be aware of the diagnosis des-
pite its rarity. An additional clinically relevant clue upon
neurological examination may be the “hem sign”, fast
trembling of the hem of the skirt or long shirt covering
the thigh of the patient, reflecting the high frequency leg
tremor in the prolonged standing condition (Additional
file 1: Video S1). High frequency (13–18 Hz) rhythmic
bursts of muscular activity can be detected on surface
Table 1 Characteristics of primary orthostatic tremor
Motor features Non motor features Electrophysiological & neuro-imaging findings
Lower body tremor activated on standing
position
Fear of falling Tremor frequency 13–18 Hz (high inter-muscular
coherence)
Tremor absent when sitting and lying Pain Brain neuroimaging (MRI) normal range
Primarily affects the legs and trunk
(Tremor may be observed in the shoulders/arms





Cerebello-thalamocortical structural and functional
abnormalities
Unsteadiness while standing Social phobia
(Self-withdrawal)
Urge to search support to feel stable
Worsening over time (same tremor frequency,
increased amplitude)
Arm postural tremor (6–8Hz)
Alteration of attention, executive function,
visuospatial ability, & visual memory (>60 y.o.)
MRI magnetic resonance imaging, DAT scan dopamine transporter imaging, y.o. years-old
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electromyography in POT, as part of the diagnosis criteria
established by the Movement Disorders Society [1]. This
patient also reports the lesser well-known non-motor
symptoms, such as anxiety, depression, social avoidance
and reduction of leisure activities, loss of self-esteem, fa-
tigue, stigma, and self-withdrawal. This patient’s emotional
experience is not unique. Many of our POT patients had
anxiety as part of the emotional burden [3]. Moreover,
fatigue, depression and social avoidance reported our
patient are in line with the higher scores for somatic con-
cerns, anxiety related disorders, depression and antisocial
features described in a recent case control study including
16 POT patients [5, 6].
Overall, the recent cases series on large number of
patients [2–4] report that the majority of POT cases were
in women (63 to 76%) with a wide range of age at onset
(range 37–88) [3, 4] with similar clinical descriptions
of symptoms and consistent high-frequency tremor,
pathognomonic of this disorder. The outcome of the con-
dition was poor. On long-term follow-up (5–25 years) [3],
there was not change of tremor frequency but 80 to 90% of
the patients reported that their symptoms became more
severe, with immediate instability upon standing, and falls
in 24% of cases [4]. Arm tremor was observed on leaning
and, over time, 70% of the patients developed postural
upper limb tremor [3]. The patients who reported symp-
tom worsening had a longer duration (median 15 years)
[3]. Treatments were overall unsatisfactory over time.
Clonazepam appears to be the most effective (one third of
the patients with moderate or marked improvement)
followed by gabapentin (900–1800 mg/day) [2–4]. The
effects of other medications were even more limited and
inconsistent (Table 2). The beneficial effect of clonazepam
diminished over time and few patients experienced benefit
from subsequent drugs [4]. Reports of thalamic deep brain
stimulation and spinal cord stimulation are scarce. Recent
advances in neuroimaging have pointed towards the
cerebello-thalamo-cortical network [7]. This paves the way
to network-based innovative treatments, as medical and
surgical interventions are only partially efficient [3, 4, 8].
Table 2 Treatment options in primary orthostatic tremor
Drugs/Neurostimulation Doses Reported clinical effect
Clonazepam 0.5 mg- 6 mg /day Moderate to marked benefit in 50 to 30% of the patients
Gabapentin 300–2400 mg/day Moderate to marked benefit
Beta-blockers (propranolol 20–240 mg/day Little effect of POT. May improve arm postural tremor
Primidone 125–250 mg/day No effect, poor tolerance
L-Dopa Pramipexolea 300–800 mg/day Rare cases (short term benefit)b
Antiepileptic drugs (valproic acid, phenobarbital,
carbamazepine, levetiracetam, topiramate, pregabalin)
Minimal to no effect
Few cases. No prolonged treatments
cDeep Brain stimulation
Spinal cord stimulation
Thalamusc Rare cases. Variable results. Some increase in time in
the upright position.
Botulinum toxin (tibial anterior) No beneficial effect
PD Parkinson’s disease
aAnecdotal effect of pramipexole bL-Dopa or pramipexole may help in slow orthostatic tremor in Parkinson’s disease, little or no benefit on POT preceding or
associated with PD. cDeep brain stimulation of the thalamus (Ventral intermediate nucleus Vim) same target as in Essential Tremor
Table 3 Secondary orthostatic tremors
Associated clinical features neuro-imaging abnormalities High/slowtremor frequency Neurological disorders
Parkinsonism, gait difficulty, postural instability Slow 6–7 Hz tremor Acqueduc stenosis
Truncal ataxia, cranial nerve involvement Fast orthostatic tremor (15 Hz) Pontine lesions/midbrain lesions
Broad based ataxic gait, cerebellar tremor, dysmetria, speech
involvement, saccadic pursuit, dysmetria of saccades
From fast 14–15 Hz tremor to the
lower range of OT (13 Hz tremor)
Cerebellar degeneration, Spino-cerebellar
ataxia (genetic, e.g. SCA2)
Ataxia, sensory disturbances, pyramidal signs, relapsing
remitting/progressive
Very slow 4 Hz tremor Multiple sclerosis
Postural instability, urinary symptoms 14–13 Hz Spinal cord lesion
Sensory disturbances, mild weakness of the upper limbs,
postural tremor
6–7 Hz Neuropathy (IgG and IgA gammapathy or
polyradiculopathy, paraneoplasic disorders
Rare cases of orthostatic tremor have been reported with dopamine blocker agents (neuroleptics), vitamin B12 deficiency (same frequency as POT°, spastic
paraparesis (16 Hz), stiff-person and Graves disease
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POT mostly appears as an isolated disorder as up to
85% of the cases never evolved towards another condi-
tion [3, 4]. Those with additional disorders were named
“orthostatic tremor plus” [9] and were mainly associated
with parkinsonism, restless legs syndrome, tardive dys-
kinesia or mild cognitive impairment. Some patients
with unsteadiness upon standing may be mistaken for
POT but are found to have slow orthostatic tremor on
neurophysiological testing. They have greater gait distur-
bances at an early stage and a higher risk of falls [10]
and overall, slow orthostatic tremor (<10Hz) bears little
resemblance with POT [10]. Extensive description of
secondary orthostatic tremors is beyond our scope as a
number of them did not have the typical high frequency
tremor [11, 12]. Some findings are in favour of se-
condary orthostatic tremor (Table 3). Medic, Dysmetria,
ataxia, eye movement disorders, sensory deficits or limbs
weakness, combined with medical history (including
neuroleptics of recreational solvants absorption) and
structural abnormalities on brain or spinal cord imaging
are valuable clues for symptomatic orthostatic tremor
(Table 3) [11, 12].
Overall, careful clinical history and clinical examin-
ation, may helpneurologists and non neurologists to de-
tect patients with POT, who were misdiagnosed and did
not receive adequate treatments and attention.
Additional file
Additional file 1: Video S1. The “hem sign”: fast trembling of the hem
of the skirt, revealing legs and thighs orthostatic tremor. (MP4 507 kb)
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